Alan Bernstein

Last updated
Alan Bernstein
Born (1947-06-25) June 25, 1947 (age 76) [1]
Alma mater University of Toronto
Known for Health research
Science policy
Mentorship
Leadership
Awards FRSC (1991)
Order of Canada (2002)
Gairdner Wightman Award 2008)
Canadian Medical Hall of Fame (2015)
Order of Ontario (2017)
Scientific career
Institutions Canadian Institute for Advanced Research
Canadian Institutes of Health Research
Global HIV Vaccine Enterprise
Imperial Cancer Research Fund
Mount Sinai Hospital, Toronto
Ontario Cancer Institute
Thesis A Genetic Analysis of the TOL(A,B) Locus of Escherichia Coli K-12  (1972)

Alan Bernstein CC OOnt FRSC (born June 25, 1947) is Professor Emeritus at the University of Toronto and President Emeritus of CIFAR, where he served as President and CEO from 2012 to 2022. A Distinguished Fellow at the Munk School of Global Affairs and Public Policy, he is also a Fellow and Member of the Standing Committee for Science Planning at the International Science Council (2022-2025). Bernstein is recognized as a leader in health research, science policy, mentorship and organizational leadership.

Contents

Education

Born in Toronto, Bernstein attended Oakwood Collegiate Institute, [2] and then received his BSc. (Honours) and the James Loudon Gold Medal in Mathematics and Physics from the University of Toronto in 1968. [3] He pursued biomedical research and obtained his Ph.D. at the University of Toronto in 1972 under the supervision of James Till with a thesis focusing on a genetic analysis of membrane mutants Escherichia coli . [4]

Career

Following his PhD, Bernstein undertook postdoctoral research in London at the Imperial Cancer Research Fund, where he began working on retroviruses and their oncogenes. [5]

Bernstein returned to Canada in 1974 to join the faculty of the Ontario Cancer Institute. In 1985, he joined the new Samuel Lunenfeld Research Institute at Mount Sinai Hospital as Head of the Division of Molecular and Developmental Biology, and then served as its director of research from 1994 to 2000. [6]

In 2000, Bernstein became the inaugural president of the Canadian Institutes of Health Research (CIHR), where he oversaw the transformation of health research in Canada and championed women, early career scientists, and the importance of interdisciplinary team research. [7]

In 2007, he became the first executive director of the Global HIV Vaccine Enterprise, an alliance of independent organizations around the world dedicated to accelerating the development of a preventive HIV vaccine. [5] As executive director, Bernstein oversaw the enterprise and led the development of the 2010 Scientific Strategic Plan for HIV vaccine development. [8]

In 2012, Bernstein joined CIFAR as president and CEO, where he was responsible for developing and leading the Institute's overall strategic direction. Under his presidency, the organization launched two Global Calls for Ideas [9] and the CIFAR Azrieli Global Scholars program for early career investigators, as well as expanding the delivery of knowledge mobilization and public engagement activities, [10] and moving in to offices in the MaRS Discovery District. [11] It was during his leadership that the Government of Canada asked CIFAR to develop and lead the Pan-Canadian Artificial Intelligence Strategy. [12] Upon his departure from CIFAR, a $1 million scholarship fund was created by donors in his name for select CIFAR Azrieli Global Scholars who become CIFAR Fellows. [13]

Bernstein continues to be an active member of many advisory and review boards in Canada, the U.S., U.K., Italy, and Australia, including the Bill & Melinda Gates Foundation [14] and the Lady Davis Institute for Medical Research. [15] He also served as co-chair of the Scientific Advisory Committee for Stand Up to Cancer Canada with Phillip A. Sharp and chairs the Global Health Award Committee for the Gairdner Foundation. [16]

Bernstein is a vocal advocate for interdisciplinary research, early-career investigators, and intellectual freedom. [17] [18] In his public remarks, he often emphasizes the importance of early-career researchers and diversity in science. [19] [20]

Research

Bernstein's research interests have centered on blood cell formation (hematopoiesis), cancer and embryonic development. He has authored more than 225 peer-reviewed scientific publications.

Awards

For his contributions to science in Canada, and internationally, Bernstein has received numerous awards, including:

He is also the recipient of honorary degrees from Dalhousie University (2007), [34] the University of British Columbia (2009), [35] the University of Ottawa (2009), [36] McGill University (2010), [37] Queen's University (2013), [38] the University of Sherbrooke (2014), [39] the University of Toronto (2019), [40] and Western University (2019). [41]

Related Research Articles

<span class="mw-page-title-main">James Orbinski</span> Canadian physician, humanitarian activist, author and leading scholar in global health

James Jude Orbinski, is a Canadian physician, humanitarian activist, author and leading scholar in global health. Orbinski was the 2016-17 Fulbright Visiting professor at the University of California, Irvine, and as of September 1, 2017, he is professor and inaugural director of the Dahdaleh Institute of Global Health Research at York University in Toronto, Ontario, Canada. He was previously the CIGI Chair in Global Health Governance at the Balsillie School of International Affairs and Wilfrid Laurier University (2012-2017), Chair of Global Health at the Dalla Lana School of Public Health (2010-2012) and full professor at the Faculty of Medicine, University of Toronto (2003-2012), where he was the founding Saul Rae Fellow at Massey College. Orbinski's current research interests focus on the health impacts of climate change, medical humanitarianism, intervention strategies around emerging and re-emerging infectious diseases, and global health governance.

<span class="mw-page-title-main">Peter Piot</span> Belgian microbiologist (born 1949)

Sir Peter Karel, Baron Piot, is a Belgian-British microbiologist known for his research into Ebola and AIDS.

The Gairdner Foundation is a non-profit organization devoted to the recognition of outstanding achievements in biomedical research worldwide. It was created in 1957 by James Arthur Gairdner to recognize and reward the achievements of medical researchers whose work contributes significantly to improving the quality of human life. Since the first awards were made in 1959, the Gairdner Awards have become Canada's most prestigious medical awards, recognizing and celebrating the research of the world’s best and brightest biomedical researchers. Since 1959, more than 390 Canada Gairdner Awards have been given to scientists from 35 countries; of these recipients, 95 have subsequently gone on to win a Nobel Prize.

<span class="mw-page-title-main">Stanley Plotkin</span> American physician

Stanley Alan Plotkin is an American physician who works as a consultant to vaccine manufacturers, such as Sanofi Pasteur, as well as biotechnology firms, non-profits and governments. In the 1960s, he played a pivotal role in discovery of a vaccine against rubella virus while working at Wistar Institute in Philadelphia. Plotkin was a member of Wistar’s active research faculty from 1960 to 1991. Today, in addition to his emeritus appointment at Wistar, he is emeritus professor of Pediatrics at the University of Pennsylvania. His book, Vaccines, is the standard reference on the subject. He is an editor with Clinical and Vaccine Immunology, which is published by the American Society for Microbiology in Washington, D.C.

Joseph Louis Rotman,, was a noted Canadian businessman and philanthropist. Rotman was the founder, benefactor and member of many successful organizations, such as the Clairvest Group Inc., the Rotman Research Institute, the Rotman School of Management, and the Rotman Institute of Philosophy. Throughout his life, he received three honorary degrees, as well as an induction into the Canadian Business Hall of Fame. He is well-regarded for donating his time and financial assistance to numerous philanthropic causes including the arts, education and healthcare.

<span class="mw-page-title-main">Canadian Institutes of Health Research</span> Canadian federal agency

The Canadian Institutes of Health Research is a federal agency responsible for funding health and medical research in Canada. Comprising 13 institutes, it is the successor to the Medical Research Council of Canada.

Sir Roy Malcolm Anderson is a leading international authority on the epidemiology and control of infectious diseases. He is the author, with Robert May, of the most highly cited book in this field, entitled Infectious Diseases of Humans: Dynamics and Control. His early work was on the population ecology of infectious agents before focusing on the epidemiology and control of human infections. His published research includes studies of the major viral, bacterial and parasitic infections of humans, wildlife and livestock. This has included major studies on HIV, SARS, foot and mouth disease, bovine tuberculosis, bovine spongiform encephalopathy (BSE), influenza A, antibiotic resistant bacteria, the neglected tropical diseases and most recently COVID-19. Anderson is the author of over 650 peer-reviewed scientific articles with an h-index of 125.

<span class="mw-page-title-main">Lorne Babiuk</span> Canadian scientist specializing in immunology, pathogenesis, virology,

Lorne Allan Babiuk, is a Canadian scientist specializing in immunology, pathogenesis, virology, molecular virology, and vaccinology. He is the Vice-President of Research at the University of Alberta and the former Director of the Vaccine and Infectious Disease Organization at the University of Saskatchewan. Dr Babiuk holds the Canada Research Chair in Vaccinology and Biotechnology and is Chair of the Board for Pan-Provincial Vaccine Enterprise (PREVENT), a vaccine development company.

Sir John Irving Bell is a Canadian-British immunologist and geneticist. From 2006 to 2011, he was President of the United Kingdom's Academy of Medical Sciences, and since 2002 he has held the Regius Chair of Medicine at the University of Oxford. He was since 2006 Chairman of the Office for Strategic Coordination of Health Research (OSCHR) but in 2020 became a normal member. Bell was selected to the Vaccine Taskforce sometime before 1 July 2020. Bell is also on the board of directors of the SOE quango Genomics England.

<span class="mw-page-title-main">Michael R. Hayden</span>

Michael R. Hayden, is a Killam Professor of Medical Genetics at the University of British Columbia, the highest honour UBC can confer on any faculty member. Only four such awards have ever been conferred in the Faculty of Medicine. Dr. Hayden is also Canada Research Chair in Human Genetics and Molecular Medicine. Hayden is best known for his research in Huntington disease (HD).

<span class="mw-page-title-main">Quarraisha Abdool Karim</span>

Quarraisha Abdool Karim is an infectious diseases epidemiologist and co-founder and Associate Scientific Director of CAPRISA. She is a Professor in Clinical Epidemiology, Columbia University, New York and Pro-Vice Chancellor for African Health, University of KwaZulu-Natal, South Africa.

<span class="mw-page-title-main">Salim Abdool Karim</span> South African medical researcher

Salim S. Abdool Karim, MBChB, MMed, MS(Epi), FFPHM, FFPath (Virol), DipData, PhD, DSc(hc), FRS is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives.

Francis Allan Plummer was a Canadian scientist, academic and HIV/AIDS researcher. He was "a recognized specialist in infectious diseases whose work influenced public health policy in Canada and abroad". He was Distinguished Professor Emeritus of Medicine and Medical Microbiology at the University of Manitoba and Scientific Director General, National Microbiology Laboratory.

B. Brett Finlay, is a Canadian microbiologist well known for his contributions to understanding how microbes cause disease in people and developing new tools for fighting infections, as well as the role the microbiota plays in human health and disease. Science.ca describes him as one of the world's foremost experts on the molecular understanding of the ways bacteria infect their hosts. He also led the SARS Accelerated Vaccine Initiative (SAVI) and developed vaccines to SARS and a bovine vaccine to E. coli O157:H7. His current research interests focus on pathogenic E. coli and Salmonella pathogenicity, and the role of the microbiota in infections, asthma, and malnutrition. He is currently the UBC Peter Wall Distinguished Professor and a Professor in the Michael Smith Laboratories, Microbiology and Immunology, and Biochemistry and Molecular Biology, and Co-director and Senior Fellow for the CIFAR Humans and Microbes program. He is also co-author of the book Let Them Eat Dirt: Saving Your Child from an Oversanitized World and The Whole-Body Microbiome: How to Harness Microbes - Inside and Out - For Lifelong Health. Finlay is the author of over 500 publications in peer-reviewed journals and served as editor of several professional publications for many years.

<span class="mw-page-title-main">Helen Rees</span>

Professor Helen Rees OBE GCOB D.Sc. Medicine LLD is a medical doctor, and the founder and executive director of Wits RHI, the largest research Institute at the University of the Witwatersrand in Johannesburg, South Africa. She is a Personal Professor in the University of Witwatersrand's Department of Obstetrics and Gynaecology, co-director and co-founder of the Wits African Leadership in Vaccinology Expertise (ALIVE), Honorary Professor in the Department of Clinical Research at the London School of Hygiene and Tropical Medicine and an Honorary Fellow at Cambridge University's Murray Edwards College, UK.

Lewis Edward Kay, is a Canadian academic and biochemist known for his research in biochemistry and nuclear magnetic resonance spectroscopy for the studies of the structure and behaviour of proteins. He is a professor of molecular genetics, biochemistry and chemistry at the University of Toronto and Senior Scientist in Molecular Medicine at The Hospital for Sick Children.

Colleen M. Flood is the Dean of Queen's University Faculty of Law.

James (Jim) Woodgett is a British-born biologist and the Principal Investigator of an active research laboratory at the Lunenfeld-Tanenbaum Research Institute, Sinai Health System, in Toronto, Ontario, Canada. He was the Koffler Director of Research at the Lunenfeld-Tanenbaum Research Institute from November 2005 to January 2021.

Nubia Muñoz is a Colombian medical scientist and epidemiologist, whose research has been instrumental in establishing that human papillomavirus (HPV) infection is the primary cause of cervical cancer which has led to the development of a vaccine that is capable of preventing 70% of all cervical cancers.

References

  1. ↑ "Alan Bernstein". Canadian Who's Who. Grey House Publishing Canada. Retrieved 7 October 2019.
  2. ↑ Gasner, Cynthia (May 15, 2008). "Oakwood CI marks 100 years". Canadian Jewish News.
  3. ↑ Kalvapalle, Rahul (June 10, 2019). "Pioneering health researcher Alan Bernstein receives U of T honorary degree". University of Toronto. U of T News. Retrieved 3 October 2019.
  4. ↑ Bernstein, Alan (1972). A Genetic Analysis of the TOL(A,B) Locus of Escherichia Coli K-12 (PhD thesis). University of Toronto. ProQuest   302687855.
  5. 1 2 Virginia, Gewin (November 8, 2007). "Physics student turned biomedical scientist becomes executive director of Global HIV Vaccine Enterprise". Nature. 450 (7167): 316. doi: 10.1038/nj7167-316a .
  6. ↑ "Alan Bernstein, OC, PhD - Canada Gairdner Wightman Award 2008". Gairdner. Retrieved 4 October 2019.
  7. ↑ Bernstein, Alan (October 12, 2017). "It's time for a bold new vision for Canadian fundamental science". Rogers Media. Maclean's. Retrieved 7 October 2019.
  8. ↑ Berkley, Seth (September 2010). "The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise". Nature Medicine. 16 (9): 981–989. doi: 10.1038/nm0910-981 . PMID   20823883.
  9. ↑ "Global Call for Ideas". CIFAR. Retrieved 4 October 2019.
  10. ↑ Farrow, Jon (17 July 2019). "CIFAR announces public engagement initiatives". CIFAR. Retrieved 4 October 2019.
  11. ↑ "CIFAR is moving to MaRS!". CIFAR. Retrieved 4 October 2019.
  12. ↑ "Building an AI World: Report on National and Regional AI Strategies". CIFAR. Retrieved 8 May 2023.
  13. ↑ "CIFAR researcher Carolina Tropini is appointed Alan Bernstein Fellow". CIFAR. Retrieved 8 May 2023.
  14. ↑ "Who We Are: Scientific Advisory Committee". Bill & Melinda Gates Foundation. Retrieved 4 October 2019.
  15. ↑ "International Scientific Advisory Board". Lady Davis Institute/Jewish General Hospital. Retrieved 4 October 2019.
  16. ↑ "Gairdner Global Health Advisory Committee". Gairdner. Retrieved 4 October 2019.
  17. ↑ Bernstein, Alan; Rossant, Janet (April 19, 2017). "A clear call to move Canadian research forward". The Globe and Mail. The Globe and Mail. Retrieved 4 October 2019.
  18. ↑ "Alan Bernstein: Doubt Everything" (Video). YouTube.com. November 5, 2015. Retrieved 4 October 2019.
  19. ↑ "Alan Bernstein, convocation 2019 honorary degree recipient" (Video). YouTube.com. June 14, 2019. Retrieved 4 October 2019.
  20. ↑ "Alan Bernstein - Honouree at Testimonial Dinner & Awards 2019" (Video). YouTube.com. April 12, 2019. Retrieved 4 October 2019.
  21. ↑ "Fellows". Royal Society of Canada. Retrieved 4 October 2019.
  22. ↑ McLaughlin Medal Archived 2011-03-05 at the Wayback Machine
  23. ↑ "GSC William F Grant and Peter B Moens Award of Excellence". Genetics Society of Canada. Retrieved 4 October 2019.
  24. ↑ "Australia honours Bernstein for his work in health research". Friends of CIHR. Retrieved 4 October 2019.
  25. ↑ "Officer of the Order of Canada". The Governor General of Canada. Retrieved 4 October 2019.
  26. ↑ "Order of Canada appointees – June 2023". The Governor General of Canada. June 30, 2023. Retrieved June 30, 2023.
  27. ↑ "Queen Elizabeth II's Golden Jubilee Medal (2002)". The Governor General of Canada. Retrieved 4 October 2019.
  28. ↑ "Médaille du mérite de l'IRCM" (PDF). l’Institut de recherches cliniques de Montréal (IRCM). Retrieved 4 October 2019.
  29. ↑ "Alan Bernstein: Canada Gairdner Wightman Award 2008". Gairdner. Retrieved 4 October 2019.
  30. ↑ "Queen Elizabeth II's Diamond Jubilee Medal (2012)". The Governor General of Canada. Retrieved 4 October 2019.
  31. ↑ "Dr. Alan Bernstein, 2017 Friesen Prize". Friends of CIHR. Retrieved 4 October 2019.
  32. ↑ "The 2017 Appointees to the Order of Ontario". Province of Ontario, Ministry of Citizenship and Immigration. January 29, 2018. Retrieved 7 October 2019.
  33. ↑ "Testimonial Dinner and Awards 2019". Public Policy Forum. Retrieved 4 October 2019.
  34. ↑ "2000 - 2009 Honorary Degree Recipients". Dalhousie University. Archived from the original on 9 April 2019. Retrieved 4 October 2019.
  35. ↑ "2009 Honorary Degree Recipients". The University of British Columbia. Retrieved 4 October 2019.
  36. ↑ "Alan Bernstein". University of Ottawa. Retrieved 7 October 2019.
  37. ↑ "McGill to recognize outstanding individuals with honorary degrees". McGill University. May 17, 2010. Retrieved 4 October 2019.
  38. ↑ "Honorary degree recipients straddle science, politics". Queen's University. Queen's Gazette. May 21, 2013. Retrieved 4 October 2019.
  39. ↑ Dubois, Caroline (September 18, 2014). "Quatre personnalités reçoivent un doctorat honorifique". L'Université de Sherbrooke. Retrieved 4 October 2019.
  40. ↑ Farrow, Jon (February 28, 2019). "CIFAR President and CEO Dr. Alan Bernstein to receive honorary degree from the University of Toronto". CIFAR. Retrieved 7 October 2019.
  41. ↑ "Western to honour global academic, science and financial leaders at 313th Convocation". Western University. March 26, 2019. Retrieved 4 October 2019.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.